helz Antibody

What is HELZ protein and why is it significant in research?

HELZ (helicase with zinc finger, also known as DHRC or HUMORF5) is a nuclear protein comprising 1,942 amino acids with a characteristic C3H1-type zinc finger domain. HELZ belongs to the RNA helicase superfamily and plays vital roles in modifying RNA structure by unwinding double-stranded RNA regions, thereby altering RNA conformation and influencing biological activity. This protein is ubiquitously expressed during embryonic development and is essential for proper development of multiple organs and tissues . HELZ's ability to interact with various RNA molecules makes it significant for research in gene regulation, cellular function, and developmental biology.

What types of HELZ antibodies are available for research applications?

The primary types of HELZ antibodies available include monoclonal antibodies like HELZ Antibody (FA-52), which is a mouse IgG2b kappa light chain antibody that detects human HELZ protein . Polyclonal antibodies are also available, such as the rabbit polyclonal antibodies that have been validated for use in multiple applications . These antibodies are available in non-conjugated forms and have been validated for specific applications including western blotting, immunoprecipitation, and immunofluorescence. For comprehensive studies, researchers can select antibodies based on the epitope region and species specificity requirements.

How does HELZ function in cellular processes and what research methods can investigate this?

HELZ functions primarily as an RNA helicase that modifies RNA structure by unwinding double-stranded regions. This activity is crucial for proper embryonic development and cellular processes including translation. Recent research has also implicated HELZ in DNA repair mechanisms, specifically in promoting R loop resolution to facilitate DNA double-strand break repair by homologous recombination . To investigate these functions, researchers can employ multiple methodologies including:

• RNA-protein interaction studies using DRIP (DNA-RNA immunoprecipitation)

• Functional assays following HELZ depletion using siRNA or CRISPR knockout systems

• Immunofluorescence to detect R loops using S9.6 antibody after HELZ manipulation

• Rescue experiments with wild-type versus mutant HELZ (e.g., K674N mutation that abolishes ATPase activity)

What are the optimal protocols for using HELZ antibodies in Western blotting?

For Western blotting applications with HELZ antibodies, researchers should consider the following methodological approach:

• Sample preparation: Extract proteins using RIPA buffer supplemented with protease inhibitors

• Gel electrophoresis: Use 6-8% SDS-PAGE gels due to HELZ's large size (1,942 amino acids)

• Transfer: Employ wet transfer at lower voltage (30V) overnight for complete transfer of large proteins

• Blocking: Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Primary antibody incubation: Dilute HELZ antibody (FA-52) at 1:600 and incubate for 1.5 hours at room temperature

• Washing: Wash membranes 3-5 times with TBST

• Secondary antibody incubation: Use appropriate anti-mouse IgG secondary antibody

• Detection: Employ enhanced chemiluminescence for visualization

This protocol has been validated for detecting endogenous HELZ in cell lines such as HeLa, with expected band size exceeding 200 kDa.

How can researchers optimize immunofluorescence protocols with HELZ antibodies?

For optimal immunofluorescence results with HELZ antibodies, researchers should follow these methodological steps:

• Cell preparation: Culture cells on coverslips and fix with -20°C ethanol for 10 minutes

• Permeabilization: Permeabilize fixed cells with 0.2% Triton X-100 in PBS for 10 minutes

• Blocking: Block with 3% BSA in PBS for 30-60 minutes at room temperature

• Primary antibody: Dilute HELZ antibody to 1:400 in blocking solution and incubate overnight at 4°C

• Washing: Wash 3 times with PBS containing 0.1% Tween-20

• Secondary antibody: Apply fluorophore-conjugated secondary antibody (e.g., CoraLite®488-Conjugated anti-rabbit IgG) at 1:1000 dilution for 1 hour at room temperature

• Nuclear counterstaining: Counterstain with DAPI

• Mounting: Mount slides with anti-fade mounting medium

• Imaging: Visualize using confocal microscopy with appropriate filter sets

This method has been validated for detecting HELZ in HepG2 cells, with expected nuclear localization pattern.

What controls are essential for validating HELZ antibody specificity in experimental designs?

When using HELZ antibodies, the following controls are essential to validate antibody specificity:

• Knockdown/knockout controls:

  • siRNA-mediated HELZ depletion (validated using multiple siRNAs targeting different regions)

  • CRISPR/Cas9 knockout using HELZ CRISPR/Cas9 KO plasmids

  • Compare antibody signal in wildtype versus HELZ-depleted samples

• Overexpression controls:

  • Transfection with GFP/RFP-tagged HELZ constructs

  • Verification of antibody recognition of both endogenous and overexpressed HELZ

• Peptide competition assays:

  • Pre-incubation of antibody with immunizing peptide before application

  • Gradual disappearance of signal with increasing peptide concentration

• Cross-reactivity assessment:

  • Testing antibody on samples from different species to confirm species specificity

  • Verification against negative control tissues known not to express HELZ

The successful validation of antibody specificity has been demonstrated in previous studies, such as the verification that the HELZ antibody recognizes both endogenous HELZ and overexpressed GFP/RFP-HELZ constructs .

How does HELZ contribute to DNA repair mechanisms and what experimental approaches can elucidate this function?

Recent research has revealed that HELZ plays a critical role in DNA repair, specifically in promoting R loop resolution to facilitate DNA double-strand break (DSB) repair through homologous recombination (HR) . To investigate this function, researchers can employ these advanced experimental approaches:

• Sensitivity assays:

  • Deplete HELZ using siRNA and assess cellular sensitivity to DNA-damaging agents (etoposide, ionizing radiation, camptothecin)

  • Validated results showed HELZ depletion causes hypersensitivity to these agents

• R loop detection:

  • Immunofluorescence using S9.6 monoclonal antibody to detect R loops

  • Slot blot analysis with S9.6 antibody

  • Include RNase H treatment controls to confirm R loop specificity

  • Results demonstrated increased S9.6 signal with HELZ depletion, rescuable by RNase H treatment

• Functional rescue experiments:

  • Overexpress wild-type GFP-HELZ versus K674N mutant (defective in ATPase activity)

  • Assess R loop levels using S9.6 signal intensity

  • Findings showed only wild-type HELZ, not the K674N mutant, alleviated R loop accumulation

• DNA-RNA immunoprecipitation (DRIP):

  • Use S9.6 antibody to immunoprecipitate R loops

  • Assess HELZ interaction with R loops

  • Include RNase H or RNase A treatments as controls

  • Research showed HELZ interaction with R loops increases after DSB induction

• HR repair assessment:

  • Monitor RAD51 foci formation after ionizing radiation

  • Test if RNase H treatment rescues RAD51 foci formation in HELZ-depleted cells

  • Data indicated HELZ promotes HR by preventing R loop accumulation at DSBs

What are the technical considerations for employing HELZ antibodies in immunohistochemistry for tissue samples?

For effective immunohistochemistry using HELZ antibodies on tissue samples, researchers should consider these advanced technical aspects:

• Antigen retrieval optimization:

  • Heat-mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) is recommended

  • Optimize retrieval time (15-20 minutes) for different tissue types

• Antibody dilution testing:

  • Test dilution ranges between 1:100 to 1:500

  • For paraffin-embedded human breast cancer tissue, a 1:200 dilution has been validated

• Signal amplification strategies:

  • Consider tyramide signal amplification for low-abundance targets

  • Use polymer-based detection systems for improved sensitivity

• Counterstaining considerations:

  • Hematoxylin counterstaining time should be optimized (30 seconds to 2 minutes)

  • Consider nuclear versus cytoplasmic localization when selecting counterstains

• Multi-label approaches:

  • For co-localization studies, optimize sequential staining protocols

  • Consider spectral unmixing for multi-fluorophore approaches

• Quantification methods:

  • Establish scoring systems for HELZ expression levels

  • Consider digital image analysis for quantitative assessment

These considerations have been applied successfully in breast cancer tissue samples, demonstrating clear HELZ staining patterns under 40x magnification .

How can researchers design experiments to investigate HELZ's role in RNA metabolism?

To investigate HELZ's function in RNA metabolism, researchers can implement these methodologically rigorous experimental approaches:

• RNA-protein interaction studies:

  • RNA immunoprecipitation (RIP) using HELZ antibodies

  • CLIP-seq (cross-linking immunoprecipitation sequencing) to identify direct RNA targets

  • In vitro RNA binding assays with recombinant HELZ

• Helicase activity assays:

  • Design RNA substrates with double-stranded regions

  • Measure unwinding activity of wild-type HELZ versus K674N Walker A motif mutant

  • Assess ATP dependence of unwinding activity

• Translational impact assessment:

  • Polysome profiling following HELZ depletion

  • Ribosome profiling to assess translational efficiency

  • Puromycin incorporation assays to measure global protein synthesis

• Structure-function relationship studies:

  • Generate domain deletion constructs (zinc finger domain, helicase domain)

  • Assess functional consequences using rescue experiments

  • Employ CRISPR-based approaches for endogenous domain disruption

• Transcriptome-wide analyses:

  • RNA-seq following HELZ manipulation to identify affected transcripts

  • Alternative splicing analyses to detect splicing changes

  • RNA stability assays to determine effects on transcript half-lives

These approaches build on the established understanding that HELZ plays vital roles in modifying RNA structure through its helicase activity, which is essential for proper development and cellular function .

What are common technical challenges when using HELZ antibodies and how can they be addressed?

Researchers working with HELZ antibodies may encounter several technical challenges that can be addressed with the following methodological approaches:

• Detection of high molecular weight protein:

  • Challenge: HELZ's large size (1,942 amino acids) makes complete transfer difficult

  • Solution: Use gradient gels (4-12%), extend transfer time (overnight at 30V), and employ specialized transfer buffers containing SDS and methanol

• Background signal in immunofluorescence:

  • Challenge: Non-specific binding causing high background

  • Solution: Optimize blocking (5% BSA + 5% normal serum matching secondary antibody host), extend blocking time (2+ hours), and incorporate additional washing steps

• Variability in immunoprecipitation efficiency:

  • Challenge: Inconsistent pull-down of HELZ protein

  • Solution: Pre-clear lysates thoroughly, optimize antibody-to-bead ratio, extend incubation time to overnight at 4°C, and use gentle washing buffers

• Cross-reactivity with related helicases:

  • Challenge: Potential cross-reactivity with other RNA helicases

  • Solution: Validate with HELZ knockout/knockdown controls, perform peptide competition assays, and use multiple antibodies targeting different HELZ epitopes

• Epitope masking in fixed tissues:

  • Challenge: Formalin fixation may mask the epitope

  • Solution: Test multiple antigen retrieval methods (Tris-EDTA pH 9.0, citrate buffer pH 6.0) and optimize retrieval duration

How can researchers quantitatively analyze HELZ expression levels in different experimental conditions?

For quantitative analysis of HELZ expression across experimental conditions, researchers should implement these methodologically sound approaches:

• Western blot quantification:

  • Use housekeeping proteins (β-actin, GAPDH) as loading controls

  • Employ digital image analysis software (ImageJ, Image Lab) for densitometry

  • Ensure linear dynamic range by testing multiple exposure times

  • Normalize HELZ signal to loading control for accurate comparisons

• qRT-PCR for transcript analysis:

  • Design primers spanning exon-exon junctions

  • Validate primer efficiency using standard curves

  • Use multiple reference genes for normalization (GAPDH, ACTB, HPRT)

  • Apply the 2^-ΔΔCt method for relative quantification

• Immunofluorescence quantification:

  • Capture images with identical exposure settings

  • Measure nuclear HELZ signal intensity using software like ImageJ

  • Analyze large numbers of cells (>100 per condition)

  • Consider signal-to-background ratio for accurate measurements

• Flow cytometry:

  • Optimize cell permeabilization for nuclear protein detection

  • Use fluorophore-conjugated secondary antibodies

  • Include isotype controls to set gating parameters

  • Measure median fluorescence intensity for population analysis

• ELISA-based approaches:

  • Develop sandwich ELISA using multiple HELZ antibodies

  • Generate standard curves with recombinant HELZ protein

  • Include spike-in controls to assess recovery efficiency

  • Validate across multiple sample types (cell lysates, tissue extracts)

These quantitative approaches enable precise measurement of HELZ expression changes in response to experimental manipulations or disease states.

How might HELZ antibodies be applied in investigating cancer biology and potential therapeutic approaches?

HELZ antibodies offer significant potential for cancer biology research through these methodological applications:

• Expression profiling across cancer types:

  • Immunohistochemical analysis of tissue microarrays

  • Correlation of HELZ expression with clinical outcomes

  • Initial studies have already demonstrated HELZ detection in breast cancer tissue

• Functional studies in cancer cell lines:

  • CRISPR/Cas9 knockout using available HELZ CRISPR/Cas9 KO plasmids

  • siRNA-mediated knockdown to assess cancer-specific phenotypes

  • Overexpression studies using CRISPR activation systems

• DNA damage response investigations:

  • Study HELZ's role in DNA repair in cancer contexts

  • Assess potential synthetic lethality with existing chemotherapeutics

  • Building on findings that HELZ depletion causes hypersensitivity to DNA-damaging agents

• Biomarker development:

  • Evaluate HELZ as a potential diagnostic or prognostic biomarker

  • Develop standardized IHC scoring systems for clinical application

  • Correlate with established cancer biomarkers

• Therapeutic target assessment:

  • Screen for small molecule inhibitors of HELZ helicase activity

  • Investigate combination approaches with DNA-damaging agents

  • Explore sensitivity of HELZ-dependent cancers to R loop-stabilizing compounds

These research directions build on emerging understanding of HELZ's roles in DNA repair and cell proliferation, with potential implications for cancer therapy development.

What experimental approaches can investigate the interplay between HELZ and other DNA repair proteins?

To elucidate the functional relationships between HELZ and other DNA repair factors, researchers can implement these methodologically rigorous approaches:

• Co-immunoprecipitation studies:

  • Use HELZ antibodies to pull down interacting proteins

  • Perform reverse co-IP with antibodies against known repair factors

  • Analyze by mass spectrometry to identify novel interactors

  • Validate interactions by western blotting

• Proximity-based labeling:

  • Express HELZ fused to BioID or APEX2

  • Identify proximal proteins through streptavidin pull-down and mass spectrometry

  • Compare interactome before and after DNA damage induction

• Fluorescence microscopy co-localization:

  • Perform dual immunofluorescence for HELZ and repair factors

  • Analyze co-localization at DNA damage sites

  • Quantify temporal dynamics of recruitment

• Functional epistasis analyses:

  • Perform single and double knockdowns of HELZ and repair factors

  • Assess synthetic lethality or rescue phenotypes

  • Measure DNA repair efficiency using HR reporter assays

• Domain mapping of interactions:

  • Generate HELZ truncation mutants

  • Identify minimal domains required for interaction with repair factors

  • Assess functional consequences of disrupting specific interactions

These approaches build on the established role of HELZ in promoting R loop resolution to facilitate DNA double-strand break repair by homologous recombination .

What are the emerging technologies that may enhance HELZ antibody applications in research?

Several cutting-edge technologies hold promise for expanding HELZ antibody applications in research:

• Single-cell protein analysis:

  • Single-cell western blotting for heterogeneity assessment

  • Mass cytometry (CyTOF) with metal-conjugated HELZ antibodies

  • Microfluidic platforms for single-cell protein quantification

• Super-resolution microscopy:

  • STORM/PALM techniques for nanoscale localization of HELZ

  • Structured illumination microscopy for enhanced spatial resolution

  • Expansion microscopy for physical magnification of subcellular structures

• In situ proximity ligation:

  • Detection of HELZ interactions with specific partners in fixed cells/tissues

  • Visualization of modification-specific forms of HELZ

  • Multiplexed detection of multiple interaction networks

• Spatial transcriptomics integration:

  • Combining HELZ protein detection with spatial RNA analysis

  • Correlation of HELZ localization with local transcriptome changes

  • Multi-omic approaches linking HELZ activity to gene expression patterns

• Engineered antibody formats:

  • Single-domain antibodies (nanobodies) against HELZ for improved access to nuclear compartments

  • Bispecific antibodies for simultaneous targeting of HELZ and interacting partners

  • Intracellular antibody delivery systems for live-cell tracking

These technologies promise to provide unprecedented insights into HELZ localization, dynamics, and function in complex cellular processes.

How can researchers employ HELZ antibodies to investigate its role during embryonic development?

To explore HELZ functions during embryonic development, researchers can utilize these methodologically sound approaches:

• Developmental expression profiling:

  • Immunohistochemistry on embryonic tissue sections at different developmental stages

  • Western blot analysis of tissue-specific expression during development

  • Correlation with developmental milestones and organogenesis

• Conditional knockout approaches:

  • Generate tissue-specific or temporally controlled HELZ knockout models

  • Use available CRISPR/Cas9 systems and HDR plasmids for model creation

  • Assess developmental consequences through morphological and functional analyses

• Ex vivo developmental models:

  • Employ organoid systems with HELZ antibody staining

  • Use embryoid bodies with temporal HELZ expression analysis

  • Correlate HELZ expression with differentiation markers

• In situ hybridization-immunohistochemistry combination:

  • Dual detection of HELZ mRNA and protein

  • Assess transcriptional and post-transcriptional regulation

  • Identify tissues with potential post-transcriptional control

• Live imaging in developmental models:

  • Use fluorescently tagged HELZ antibody fragments in transparent embryo models

  • Track HELZ dynamics during critical developmental processes

  • Correlate localization changes with developmental transitions

These approaches build on the established understanding that HELZ is expressed ubiquitously during embryonic development and plays vital roles in the proper development of multiple organs and tissues .

What methodological considerations are important when using HELZ antibodies for chromatin immunoprecipitation (ChIP) studies?

For effective chromatin immunoprecipitation using HELZ antibodies, researchers should consider these specialized methodological aspects:

• Crosslinking optimization:

  • Test both formaldehyde (1-2%) and dual crosslinking approaches (DSG followed by formaldehyde)

  • Optimize crosslinking time (5-15 minutes) for efficient but reversible crosslinking

  • Consider native ChIP approaches for direct DNA-protein interactions

• Sonication parameters:

  • Optimize sonication conditions to generate 200-500 bp fragments

  • Verify fragmentation efficiency by agarose gel electrophoresis

  • Consider enzymatic fragmentation alternatives for consistent results

• Antibody validation for ChIP:

  • Perform preliminary ChIP-qPCR at known or predicted binding sites

  • Include IgG negative controls and positive controls (histone marks)

  • Validate antibody specificity under ChIP conditions using knockout controls

• Sequential ChIP considerations:

  • For co-occupancy studies with other factors, optimize elution conditions

  • Consider protein complex stability during immunoprecipitation

  • Validate each antibody individually before sequential ChIP

• ChIP-seq library preparation:

  • Optimize input amounts based on precipitation efficiency

  • Consider low-input library preparation methods for limited material

  • Include appropriate controls for peak calling and analysis

These methodological considerations ensure robust and reproducible ChIP results when investigating HELZ interactions with chromatin and potential roles in transcriptional regulation.

How can researchers integrate multi-omics approaches with HELZ antibody studies?

To comprehensively understand HELZ function through multi-omics integration, researchers can implement these methodological strategies:

• Integrative ChIP-seq and RNA-seq:

  • Perform HELZ ChIP-seq to identify genomic binding sites

  • Correlate with RNA-seq after HELZ perturbation

  • Identify direct transcriptional effects versus secondary consequences

  • Analyze enriched motifs at binding sites

• Proteomics integration:

  • Combine HELZ immunoprecipitation with mass spectrometry

  • Perform quantitative proteomics after HELZ manipulation

  • Correlate protein-level changes with transcriptome alterations

  • Identify post-transcriptional regulatory networks

• RNA structure analysis integration:

  • Perform SHAPE-seq or DMS-seq to assess RNA structural changes after HELZ perturbation

  • Connect structural alterations to functional outcomes

  • Identify direct HELZ targets through structure-based approaches

• Epigenomic correlations:

  • Integrate HELZ ChIP-seq with histone modification maps

  • Assess changes in chromatin accessibility after HELZ manipulation

  • Correlate with DNA methylation patterns in developmental contexts

• Network analysis approaches:

  • Build integrated networks incorporating HELZ protein interactions, RNA targets, and transcriptional effects

  • Identify key hubs and regulatory circuits

  • Predict functional consequences of network perturbations

These integrative approaches provide a systems-level understanding of HELZ function across multiple molecular domains, revealing emergent properties not apparent from single-omics studies.

What are the most promising research directions for understanding HELZ function using antibody-based approaches?

Based on current literature and methodological capabilities, the following research directions show particular promise:

• Mechanistic studies of HELZ in R loop biology:

  • Further characterization of HELZ's role in R loop resolution

  • Investigation of the helicase mechanism in R loop processing

  • Identification of specific RNA structures targeted by HELZ

  • Building on established findings of HELZ's role in DNA repair

• Development-specific functions:

  • Tissue-specific roles during embryogenesis

  • Temporal regulation of HELZ activity during development

  • Connections to developmental disorders

  • Based on the understanding of HELZ's ubiquitous expression during embryonic development

• Cancer biology applications:

  • Expanded profiling across cancer types

  • Therapeutic vulnerability screens in HELZ-dependent cancers

  • Biomarker development for stratification

  • Building on initial studies in breast cancer tissue

• Structure-function relationships:

  • Detailed mapping of functional domains

  • Investigation of regulatory post-translational modifications

  • Development of domain-specific antibodies

• Technological innovations:

  • Single-molecule imaging of HELZ dynamics

  • CRISPR-based endogenous tagging for physiological studies

  • Spatial multi-omics integration